174 related articles for article (PubMed ID: 25307949)
21. Pyrin, product of the MEFV locus, interacts with the proapoptotic protein, Siva.
Balci-Peynircioglu B; Waite AL; Hu C; Richards N; Staubach-Grosse A; Yilmaz E; Gumucio DL
J Cell Physiol; 2008 Sep; 216(3):595-602. PubMed ID: 18330885
[TBL] [Abstract][Full Text] [Related]
22. Current perspectives on familial Mediterranean fever.
Guz G; Kanbay M; Ozturk MA
Curr Opin Infect Dis; 2009 Jun; 22(3):309-15. PubMed ID: 19339884
[TBL] [Abstract][Full Text] [Related]
23. Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients.
Magnotti F; Lefeuvre L; Benezech S; Malsot T; Waeckel L; Martin A; Kerever S; Chirita D; Desjonqueres M; Duquesne A; Gerfaud-Valentin M; Laurent A; Sève P; Popoff MR; Walzer T; Belot A; Jamilloux Y; Henry T
EMBO Mol Med; 2019 Nov; 11(11):e10547. PubMed ID: 31589380
[TBL] [Abstract][Full Text] [Related]
24. Functional Assessment of Disease-Associated Pyrin Variants.
Chirita D; Jamilloux Y; Henry T; Magnotti F
Methods Mol Biol; 2022; 2523():179-195. PubMed ID: 35759198
[TBL] [Abstract][Full Text] [Related]
25. RIPK3 Promotes
Sharma D; Malik A; Balakrishnan A; Malireddi RKS; Kanneganti TD
J Immunol; 2020 Nov; 205(10):2778-2785. PubMed ID: 32989095
[TBL] [Abstract][Full Text] [Related]
26. The role of the pro-apoptotic protein Siva in the pathogenesis of Familial Mediterranean fever: A structural and functional analysis.
Goulielmos GN; Petraki E; Vassou D; Eliopoulos E; Iliopoulos D; Sidiropoulos P; Aksentijevich I; Kardassis D; Boumpas DT
Biochem Biophys Res Commun; 2010 Nov; 402(1):141-6. PubMed ID: 20934406
[TBL] [Abstract][Full Text] [Related]
27. Lipopolysaccharide-induced expression of multiple alternatively spliced MEFV transcripts in human synovial fibroblasts: a prominent splice isoform lacks the C-terminal domain that is highly mutated in familial Mediterranean fever.
Diaz A; Hu C; Kastner DL; Schaner P; Reginato AM; Richards N; Gumucio DL
Arthritis Rheum; 2004 Nov; 50(11):3679-89. PubMed ID: 15529356
[TBL] [Abstract][Full Text] [Related]
28. Evidence for the involvement of mTOR inhibition and basal autophagy in familial Mediterranean fever phenotype.
Mitroulis I; Kourtzelis I; Kambas K; Chrysanthopoulou A; Ritis K
Hum Immunol; 2011 Feb; 72(2):135-8. PubMed ID: 21081147
[TBL] [Abstract][Full Text] [Related]
29. The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases.
La Bella S; Di Ludovico A; Di Donato G; Basaran O; Ozen S; Gattorno M; Chiarelli F; Breda L
Front Immunol; 2023; 14():1341680. PubMed ID: 38250061
[TBL] [Abstract][Full Text] [Related]
30. Expression of the familial Mediterranean fever gene is regulated by nonsense-mediated decay.
Grandemange S; Soler S; Touitou I
Hum Mol Genet; 2009 Dec; 18(24):4746-55. PubMed ID: 19755381
[TBL] [Abstract][Full Text] [Related]
31. Pyrin and ASC co-localize to cellular sites that are rich in polymerizing actin.
Waite AL; Schaner P; Hu C; Richards N; Balci-Peynircioglu B; Hong A; Fox M; Gumucio DL
Exp Biol Med (Maywood); 2009 Jan; 234(1):40-52. PubMed ID: 19109554
[TBL] [Abstract][Full Text] [Related]
32. Familial Mediterranean fever in the post-genomic era: how an ancient disease is providing new insights into inflammatory pathways.
Schaner PE; Gumucio DL
Curr Drug Targets Inflamm Allergy; 2005 Feb; 4(1):67-76. PubMed ID: 15720238
[TBL] [Abstract][Full Text] [Related]
33. [The role of interleukin-1 and interleukin-1-receptor antagonist in development of familial mediterranean fever and other autoinflammatory diseases].
Dzhidoian Z
Georgian Med News; 2011 May; (194):53-6. PubMed ID: 21685523
[TBL] [Abstract][Full Text] [Related]
34. An overview of familial Mediterranean fever with emphasis on pyrin and colchicine.
Dbouk HA; Uthman IW
J Med Liban; 2008; 56(1):35-41. PubMed ID: 19534089
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in the molecular pathogenesis of hereditary recurrent fevers.
Masters SL; Lobito AA; Chae J; Kastner DL
Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):428-33. PubMed ID: 17088647
[TBL] [Abstract][Full Text] [Related]
36. Mutations in the B30.2 and the central helical scaffold domains of pyrin differentially affect inflammasome activation.
Chirita D; Bronnec P; Magnotti F; Dalmon S; Martin A; Popoff M; Gerfaud-Valentin M; Sève P; Belot A; Contis A; Duquesne A; Nocturne G; Lemelle I; Georgin-Lavialle S; Boursier G; Touitou I; Jamilloux Y; Henry T
Cell Death Dis; 2023 Mar; 14(3):213. PubMed ID: 36966139
[TBL] [Abstract][Full Text] [Related]
37. Cluster of patients with Familial Mediterranean fever and heterozygous carriers of mutations in MEFV gene in the Czech Republic.
Sedivá A; Horváth R; Maňásek V; Gregorová A; Plevová P; Horáčková M; Tesařová M; Toplak N; Debeljak M
Clin Genet; 2014 Dec; 86(6):564-9. PubMed ID: 24251727
[TBL] [Abstract][Full Text] [Related]
38. A population genetics study of the familial Mediterranean fever gene: evidence of balancing selection under an overdominance regime.
Fumagalli M; Cagliani R; Pozzoli U; Riva S; Comi GP; Menozzi G; Bresolin N; Sironi M
Genes Immun; 2009 Dec; 10(8):678-86. PubMed ID: 19675583
[TBL] [Abstract][Full Text] [Related]
39. The structural effect of the E148Q MEFV mutation on the pyrin protein: a study using a quantum chemistry model.
Naimushin A; Lidar M; Ben Zvi I; Livneh A
Isr Med Assoc J; 2011 Apr; 13(4):199-201. PubMed ID: 21598804
[TBL] [Abstract][Full Text] [Related]
40. Update on Pyrin Functions and Mechanisms of Familial Mediterranean Fever.
Manukyan G; Aminov R
Front Microbiol; 2016; 7():456. PubMed ID: 27066000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
